Product photo · 10mg
Reports describe submitted samples for this amount and form.
Tirzepatide
A drug studied for blood sugar and body weight.
What does the amount mean?
10 mg is an amount of material. Read the label to see whether it means per vial, per tablet, or per package.
Read more1 vial · 10mg in each vial
You can add this product to your cart. Checkout is temporarily unavailable.
Lab resultsTirzepatide, explained
A drug studied for blood sugar and body weight.
What it’s used for
Weight loss
At 72 weeks, average loss was 15.0%, 19.5% and 20.9% with 5, 10 and 15 mg, versus 3.1% with placebo.
Blood-sugar control
Mounjaro is approved to improve blood sugar in type 2 diabetes.
Sleep apnea
Zepbound is approved for moderate-to-severe obstructive sleep apnea in adults with obesity, alongside diet and exercise.
Heart outcomes
A large trial found heart events in 12.2% versus 13.1% with dulaglutide: not worse, but not proven better.
Appetite
People report less appetite and feeling full sooner.
What to expect
- Days 1–3
Appetite drops
- Weeks 1–2
Blood-sugar changes
- Weeks 2–4
Stomach and gut adjust; early nausea is common
- Months
Weight loss builds over months, not at a set weekly rate
- Week 72
15.0–20.9% average loss across doses in a large trial
Side effects & safety
Side effects
- Nausea, diarrhea, vomiting, constipation and abdominal discomfort
- Label warnings include pancreatitis, gallbladder disease and dehydration-related kidney injury
- Severe gut reactions, retinopathy (eye damage) and aspiration are also listed risks
Stop and get help if
- Severe abdominal pain
- New symptoms in the neck
- Vomiting that won't stop
- Passing very little urine
- Swelling (edema)
- Confusion
- Signs of an allergic reaction
- Severe mood changes
Avoid or check first
- Personal or family history of medullary thyroid cancer (MTC) or MEN2 — contraindicated
- Taking insulin or sulfonylureas — higher risk of low blood sugar
- Using oral birth control — the label advises a non-oral or added barrier method for 4 weeks after starting and after each dose increase
In sport
- The reference describes tirzepatide as not prohibited in 2026 or 2027, but monitored by WADA.
How much people usually take
Weight loss initiation
injectable
Weight loss progression
injectable
Weight loss optimization
injectable
Maximum weight loss
injectable
Diabetes management (mild)
injectable
Diabetes management (severe)
injectable
Weight reduction: SURMOUNT‑1
72 weeks · injectable
How to mix and store it
How many units do I draw?
How to mix5 steps
Wipe both tops
Wash your hands, then swab both rubber vial tops with alcohol. Let them dry.
Draw the water
Use a new sterile syringe to draw the water volume selected in the calculator.
Run it down the wall
Introduce the water slowly down the inside glass wall, rather than directly onto the powder.
Swirl, don’t shake
Gently swirl or roll the vial. Allow time for the powder to dissolve.
Label the vial
Write the preparation date and the amount and final volume on the vial label.
Injecting under the skinWhere, rotating sites, which syringe
Where
Subcutaneous injections go into the fatty layer beneath the skin. Common sites include the abdomen, outer thigh and upper arm. Keep at least 5 cm from the navel and avoid bruised, irritated or damaged skin.
Rotate sites
Change the spot each time. Clean the skin and let it dry.
Single-use equipment
Use a new sterile needle and syringe each time. Place used needles in a sharps container.
Storage
Storage
Refrigerated at 2–8°C.
Combining it with others
Don’t combine
- Semaglutide
Similar appetite-hormone effects may add to stomach problems and dehydration.
- Retatrutide
Similar appetite-hormone effects may add to stomach problems and dehydration.
- Survodutide
Similar appetite-hormone effects may add to stomach problems and dehydration.
- Mazdutide
Similar appetite-hormone effects may add to stomach problems and dehydration.
- Orforglipron
Similar appetite-hormone effects may add to stomach problems and dehydration.
Use caution
- Birth control pills
Birth control pills may work less reliably when starting or increasing the dose.
- IGF-1 LR3
Both lower blood sugar, which may increase the risk of it falling too low.
- MK-677
Increased hunger and blood sugar can work against the appetite-hormone effects.
- GHRP-6
One increases hunger while the other reduces it.
- Tesofensine
Concerns about heart rate, blood pressure and eating too little may add up.
- Adipotide
Kidney injury reported in animals may add to kidney strain linked to dehydration.
- Melanotan I
Nausea may get worse.
- Melanotan II
Nausea may get worse.
- PT-141
Nausea may get worse.
- Cagrilintide
Both slow stomach emptying and reduce appetite, which may add to nausea.
- Eloralintide
Slower stomach emptying.
Other combinations
What the research says
Two hormone targets
Tirzepatide acts on the appetite-hormone signals GIP and GLP-1. Other drugs target just GLP-1 or three hormone signals.
What studies found
SURMOUNT-1
Human study · 2,539 adults · 72 weeksIn 2,539 adults without diabetes, average weight changes at 72 weeks were −15.0%, −19.5% and −20.9% across the three tirzepatide groups, versus −3.1% with placebo. Reported health problems and treatment stops were also recorded.
Longer prediabetes follow-up
Human study · 1,032 adults · 176 weeks plus 17 weeks off treatmentIn 1,032 adults with obesity and prediabetes, average weight loss at 176 weeks was 12.3–19.7%, versus 1.3% with placebo. Diabetes developed in 1.3% versus 13.3%. After another 17 weeks off treatment, those figures were 2.4% versus 13.7%.
How long it stays in your body
Half-life is the time it takes for the amount in the body to fall by half. It does not tell you how long effects last.
Drag to see how much is left over time.
What it’s made of
Sequence 39 · N → C
- Tyr
- Aib
- Glu
- Gly
- Thr
- Phe
- Thr
- Ser
- Asp
- Tyr
- Ser
- Ile
- Aib
- Leu
- Asp
- Lys
- Ile
- Ala
- Gln
- Lys
- Ala
- Phe
- Val
- Gln
- Trp
- Leu
- Ile
- Ala
- Gly
- Gly
- Pro
- Ser
- Ser
- Gly
- Ala
- Pro
- Pro
- Pro
- Ser
N-to-C backbone; Aib is alpha-aminoisobutyric acid. Lys20 carries the C20 fatty-diacid linker and the C terminus is amidated. The tokens do not encode the complete acylated structure.
Molecular notes
Tirzepatide as described in the Mounjaro label. Reference molecule; no claim that a catalogue vial has the labelled medicine’s composition or quality.
Lab results
10mg · 2 linked reports
- Purity · sample result
- 99.483% / 99.519% / 99.542%
- Amount found · Tirzepatide
- Sample 1: 10.5 mgSample 2: 10.79 mgSample 3: 10.57 mg
Separate sample results, in report order.
Purity & amount
Sample batch TZ07
Bacterial toxin test
Sample batch TZ07
These are submitted-sample results, separate from general research or popularity ratings. Report presentation: Peptify Analytics. Source laboratory: Janoshik Analytical. The connection to the batch you would receive is not confirmed here.
Videos worth watching
Research conversations, with their original context.
Product details
- Form
- Vial
- Amount
- 10mg
Sources & further reading
Follow each reference to its original publication or documentation.
- Primary research · 2022Tirzepatide Once Weekly for the Treatment of Obesity (opens in a new tab)
- Primary research · 2025Tirzepatide for Obesity Treatment and Diabetes Prevention (opens in a new tab)
- Official documentationFDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (opens in a new tab)
- Official documentation · 2026Mounjaro FDA prescribing information, January 2026 (opens in a new tab)
- Primary research · 2024Population pharmacokinetics of tirzepatide (opens in a new tab)
- Primary research · 2022SURMOUNT-1 tirzepatide obesity trial (opens in a new tab)
- Primary research · 2024Modified peptide sequences in the retatrutide structural study (opens in a new tab)
- Reference reportPepSavvy: Tirzepatide (opens in a new tab)
- Official documentationCDC: Preventing Unsafe Injection Practices (opens in a new tab)
- Official documentationMedlinePlus: Subcutaneous injections (opens in a new tab)
Questions
What does 10mg mean?
It describes an amount of material in the unit stated on the label. It does not describe liquid volume, a dose, or how to prepare the product.
Read more about amountsDoes purity mean it is sterile?
No. Purity and sterility require different tests. An endotoxin result also does not establish sterility.
About testingCan I calculate concentration?
You need a mass in mg and either a final volume or a target concentration. IU and blends require separate, verified information.
Use the mixing helper for this amount ↑How can I get help with an order?
Open your order details to check its current status. Shipping and support information are available below.
Contact usMore to explore
Shop allHGH – Batch GGC41 110iu Kit
HGH Batch GGC41 is the 110iu kit listing for human growth hormone, studied for the cell-signaling pathways connecting growth hormone receptors to metabolic responses.
Single Peptides
110iu / kit
HGH – Batch GGC40 430iu Kit
HGH Batch GGC40 is the 430iu kit listing for human growth hormone, a protein hormone at the center of growth hormone receptor and metabolic-signaling research.
Single Peptides
430iu / kit
HGH – Batch GGC39 420iu Kit
HGH Batch GGC39 is the 420iu kit listing for human growth hormone, with research centered on receptor signaling, gene activity and the growth hormone–IGF-1 pathway.
Single Peptides
420iu / kit
HGH – Batch GGC38 280iu Kit
HGH Batch GGC38 is the 280iu kit listing for human growth hormone, a protein hormone studied for growth hormone receptor signaling and downstream IGF-1 biology.
Single Peptides
280iu / kit